Recent Posts
- MAPS Receives Grant of Appeal and Authorization to Study MDMA in Healthy Volunteer Therapists May 12, 2021
- Publication of MAPP1 Results in Nature Medicine: A Message from Amy Emerson, MAPS PBC CEO May 11, 2021
- MAPS’ Phase 3 Trial of MDMA-Assisted Therapy for PTSD Achieves Highly Statistically Significant Results for Patients with Severe, Chronic PTSD May 3, 2021
- First Controlled Trial of Cannabis for the Treatment of PTSD Raises no Safety Concerns, Further Research is Needed to Determine Efficacy March 17, 2021
- MAPS Public Benefit Corporation Expands Talent with Three Leadership Hires January 26, 2021